Tag: connected drug delivery devices market trends

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Connected Drug Delivery Devices Industry?

The market for connected drug delivery devices has seen a rapid expansion recently. It is forecasted to rise from a value of $7.48 billion in 2024 to $9.27 billion in 2025, experiencing a compound annual growth rate (CAGR) of 23.9%. The notable growth during the historical period is due to factors such as heightened knowledge of connected devices, the increasing significance of remote monitoring for medication compliance, enhanced patient involvement, the wide acceptance among consumers, and the swiftly escalating costs in medical management.

Growth is anticipated to be significant in the connected drug delivery devices market over the next few years, with projections reaching “$21.81 billion by 2029, thanks to a compound annual growth rate (CAGR) of 23.9%. This predicted rise during the forecast period is due largely to the escalating incidence of chronic illnesses, improved patient understanding of the importance of compliance with prescribed treatments, the rapid advancement of healthcare IT systems, increased focus on preventative care, and the broad use of connected devices in labs and hospitals for electronic health records (EHR) management. The forecast period is also expected to see a trend towards increased research and development activities, a surge in technological innovation and device connectivity, growing application of machine learning and artificial intelligence, expanding use of telehealth platforms that incorporate AR/VR technology, and greater implementation of electronic technology within healthcare devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp

What Forces Are Driving The Growth Of The Connected Drug Delivery Devices Industry?

The rising significance of remote patient monitoring is anticipated to boost the progress of the connected drug delivery device market. This healthcare approach leverages technology to remotely monitor patients’ health and medical information. By allowing accurate tracking of medication use and compliance, offering timely interventions, and delivering personalized care management, connected drug delivery devices enhance remote patient monitoring. For example, as per a survey by Vivalink Inc., a US firm specializing in digital health solutions, there was a 305% surge in clinicians employing remote patient monitoring from 20% in 2021 to 81% currently. This happened in August 2023, and 84% of these users intend to broaden their RPM usage in 2024. Consequently, the rising significance of remote patient monitoring is fueling the expansion of the connected drug delivery device market.

The connected drug delivery devices market covered in this report is segmented –

1) By Type: Standalone Components And Software, Integrated Devices

2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies

3) By Administration: Parenteral, Inhalational

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications

Subsegments:

1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software

2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices

What Upcoming Trends Are Expected To Impact The Connected Drug Delivery Devices Market Globally?

Major businesses in the connected drug delivery devices market are concentrating their efforts on developing unique technologies like digital respiratory health solutions to boost their financial performance in the sector. Digital respiratory health solutions refer to tech-enabled appliances that simplify the process of delivering medication to the respiratory system while also collecting usage and health data to foster enhanced patient results. For example, in February 2022, AptarGroup Inc., a US company that manufactures dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This groundbreaking digital tool transforms conventional metered-dose inhalers into intelligent, connected mechanisms, promoting medication compliance and management for those living with chronic respiratory illnesses like asthma, COPD, and other conditions. It provides attributes such as sensor analytics and insight, and fortifies patient adherence tracking via the BreatheSmart app, assisting in the proficient control of respiratory ailments.

Who Are The Primary Players Operating Across The Global Connected Drug Delivery Devices Market?

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Which Region Offers The Most Growth Potential For The Connected Drug Delivery Devices Market Through 2029?

North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Connected Drug Delivery Devices Market Size From 2025 to 2034?

The market for connected drug delivery devices has seen a rapid expansion in its size over recent years. The market is set to rise from a worth of $7.48 billion in 2024 to a value of $9.27 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 23.9%. The remarkable growth observed in the historic period is due to factors such as increased knowledge and usage of connected devices, the growing significance of remote patient monitoring for medication compliance, amplified patient involvement, broad consumer acceptance, and the escalating expense of medical management.

Over the coming years, the connected drug delivery devices market is forecasted to experience significant expansion. Experts predict it will reach a staggering $21.81 billion by 2029, with a compound annual growth rate (CAGR) of 23.9%. Factors contributing to this projected growth during the period include an increased prevalence of chronic diseases, enhancing awareness among patients about complying with prescribed treatments, the rapid advancement of healthcare IT infrastructure, a greater focus on preventive care, and the extensive use of connected devices in laboratories and hospitals to maintain electronic health records (EHR). The period of projection is likely to be marked by escalating R&D activities, a surge in technological innovations, the growing interconnectivity of devices, heightened use of machine learning and artificial intelligence, an increased implementation of telehealth platforms that incorporate AR/VR technologies, and the rising incorporation of electronic technology in healthcare devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Connected Drug Delivery Devices Market?

The growth of the connected drug delivery device market is anticipated to be fueled by the rising significance of remote patient monitoring. This method of healthcare delivery employs technology to monitor patient health and medical information from a distance. Connected drug delivery devices augment remote patient monitoring by accurately keeping track of medication use and compliance, enabling timely interventions, and providing individualised care management. For example, a survey by Vivalink Inc., a US-based provider of digital health solutions, revealed a 305% uptick in clinicians utilising remote patient monitoring on their patients in August 2023. The numbers rose from 20% in 2021 to 81% presently, and 84% of users are planning to extend their use of remote patient monitoring in 2024. As a result, the rising prominence of remote patient monitoring is propelling the expansion of the connected drug delivery device market.

Which Key Market Segments Comprise the Connected Drug Delivery Devices Market and Drive Its Revenue Growth?

The connected drug delivery devices market covered in this report is segmented –

1) By Type: Standalone Components And Software, Integrated Devices

2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies

3) By Administration: Parenteral, Inhalational

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications

Subsegments:

1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software

2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp

Which Areas Are Leading Regions in the Connected Drug Delivery Devices Market Expansion Across the Globe?

North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Strategic Trends Steering theConnected Drug Delivery Devices Market Direction?

In a bid to boost their market profitability, key players in the connected drug delivery devices market are placing their emphasis on the development of cutting-edge technology like digital respiratory health solutions. These technology-driven devices aid in administering medication to the respiratory system while also gathering usage and health-related data to enhance patient benefits. An example of such innovation is the HeroTracker Sense, launched in February 2022 by AptarGroup Inc., a US-based provider of dispensing packaging and drug delivery devices. This pioneering digital instrument turns conventional metered-dose inhalers into intelligent, interconnected devices, thereby improving medication compliance and management for individuals suffering from chronic respiratory conditions including asthma, COPD, among others. It comes equipped with sensors for data analysis and insights and facilitates patient adherence monitoring through the BreatheSmart app, thereby contributing to effective respiratory disease management.

View the full report here:

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

How Is the Connected Drug Delivery Devices Market Conceptually Defined?

Connected drug delivery devices are smart pharmaceutical devices that utilize digital technology to monitor, manage, and control the dispensation of medications, enhancing adherence and patient outcomes. These devices can connect to the internet, allowing for data sharing between patients and healthcare providers to track medication usage, adjust dosages, and improve treatment strategies.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13962

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Connected Drug Delivery Devices Market from 2024 to 2025?

The market size of connected drug delivery devices has witnessed considerable expansion in the previous years. It is set to escalate from $7.48 billion in 2024 to $9.29 billion in 2025, with a compound annual growth rate (CAGR) of 24.2%. The growth observed in the past years is due to factors such as heightened consciousness about connected devices, the growing significance of remote surveillance for drug compliance, augmented patient engagement, extensive consumer uptake, and the swiftly escalating expenses of medical management.

What Is the Projected Market Size of the Connected Drug Delivery Devices Market?

The market size for connected drug delivery devices is projected to experience a significant uptick in the approaching years, with an estimation to reach $21.92 billion in 2029, thanks to a hefty compound annual growth rate (CAGR) of 23.9%. Various factors contributing to this growth during the forecast period include a surge in chronic diseases, heightened patient awareness regarding following prescribed treatments, quickly advancing health IT infrastructures, a growing focus on preventative healthcare, and the widespread use of these connected devices within labs and hospitals for managing electronic health records (EHR). The forecast period is also expected to witness several trends such as a rise in R&D activities, a wave of technological innovation and heightened interconnectivity of devices, increased application of machine learning and AI, higher use of telehealth platforms integrated with AR/VR technologies, and growing use of electronic technology within healthcare devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp

Who are the Major Competitors in the Connected Drug Delivery Devices Market Outlook?

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

What Is Fueling Growth in the Connected Drug Delivery Devices Market?

The growth of the connected drug delivery device market is projected to be driven by the rising importance of remote patient monitoring. Remote patient monitoring is a method of healthcare delivery wherein technology is deployed to monitor patient health and medical data from a distance. Connected drug delivery devices enhance remote patient monitoring by enabling precise monitoring of medication usage and adherence, implementing timely interventions, and facilitating individualized care management. For example, a survey conducted by Vivalink Inc., a US-based digital health solutions provider, revealed that in August 2023 there was a 305% rise in clinicians utilizing remote patient monitoring on their patients, from 20% in 2021 to currently 81%, and 84% of these users intend to increase their use of remote patient monitoring in 2024. Consequently, the escalating importance of remote patient monitoring is propelling the expansion of the connected drug delivery device market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp

Which Connected Drug Delivery Devices Market Segments Are Growing the Fastest?

The connected drug delivery devices market covered in this report is segmented –

1) By Type: Standalone Components And Software, Integrated Devices

2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies

3) By Administration: Parenteral, Inhalational

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications

Subsegments:

1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software

2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices

Which Industry Trends Are Shaping the Future of the Connected Drug Delivery Devices Market?

Leading corporations in the connected drug delivery devices arena are prioritizing the development of ground-breaking tech, like digital respiratory health solutions, in order to amplify their market earnings. These solutions turn technology-aided devices that assist in administering medication to the respiratory system into tools that also track usage and health data to boost patient results. For example, in February 2022, AptarGroup Inc., an American manufacturer specialising in dispensing packaging and drug delivery devices, unveiled HeroTracker Sense. This pioneering digital tool revolutionizes conventional metered-dose inhalers, making them smarter and connected, thereby improving medication compliance and management for people battling chronic respiratory ailments like asthma and COPD amongst others. The tool comes with features like sensors for analytics and insight, and it bolsters patient adherence monitoring through the BreatheSmart app, contributing to the efficient handling of respiratory illnesses.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Which Countries Are Leading the Connected Drug Delivery Devices Market?

North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13962

This Report Delivers Insight On:

1. How big is the connected drug delivery devices market, and how is it changing globally?

2. Who are the major companies in the connected drug delivery devices market, and how are they performing?

3. What are the key opportunities and risks in the connected drug delivery devices market right now?

4. Which products or customer segments are growing the most in the connected drug delivery devices market?

5. What factors are helping or slowing down the growth of the connected drug delivery devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the connected drug delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Connected Drug Delivery Devices Market Expected to Grow Between 2025 And 2029?

The market for connected drug delivery devices has progressed at a rapid pace in recent years. The market, which was valued at $7.48 billion in 2024, is expected to rise to $9.29 billion in 2025, representing a compound annual growth rate (CAGR) of 24.2%. The notable growth during the historic period can be attributed to factors such as heightened awareness of connected devices, importance placed on remote monitoring for medicinal adherence, elevated patient involvement, increased consumer adoption and the swift rise in the cost of medical management.

In the forthcoming years, the market size for connected drug delivery devices is projected to experience remarkable growth, escalating to $21.92 billion by 2029 with a compound annual growth rate (CAGR) of 23.9%. The predicted progress in the forecast period is linked to the climbing incidence of chronic diseases, heightened awareness among patients about sticking to recommended treatments, quick advancements in healthcare IT infrastructure, growing focus on preventive care, and extensive use of connected devices in labs and hospitals for managing electronic health records (EHR). The forecast period is also likely to witness increased research & development activities, a upsurge in technological innovations and improved device connectivity, a soaring trend in adopting machine learning and artificial intelligence, and a rise in the integration of telehealth platforms with AR/VR technology. Additionally, increased utilization of electronic tech in healthcare devices is also anticipated.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp

What are the Fundamental Drivers and Innovations Shaping the Connected Drug Delivery Devices Market?

The growing significance of remote patient monitoring (RPM) is projected to fuel the expansion of the connected drug delivery device market. RPM is a method of healthcare delivery that leverages technology to monitor patients’ health and medical data remotely. Connected drug delivery devices can improve RPM by accurately tracking medication usage and adherence, initiating timely interventions, and enabling personalized care management. For example, a survey conducted by Vivalink Inc., a digital health solutions provider based in the US, in August 2023 showed a 305% rise in clinicians employing RPM on patients – from 20% in 2021 to 81% presently. Additionally, 84% of these users anticipate expanding their RPM usage in 2024. Hence, the escalating significance of RPM is propelling the connected drug delivery device market’s growth.

How Is the Connected Drug Delivery Devices Market Segmented?

The connected drug delivery devices market covered in this report is segmented –

1) By Type: Standalone Components And Software, Integrated Devices

2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies

3) By Administration: Parenteral, Inhalational

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications

Subsegments:

1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software

2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp

Which Regions Are Driving the Next Phase of the Connected Drug Delivery Devices Market Growth?

North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Connected Drug Delivery Devices Market?

Leading companies in the connected drug delivery devices market are concentrating on creating innovating technology like digital respiratory health solutions to boost their market profitability. The term ‘digital respiratory health solution’ for connected drug delivery devices indicates a device that employs technology to facilitate drug delivery to the respiratory system and monitors usage and health data, improving patient outcomes. For example, in February 2022, AptarGroup Inc., a US-based firm specializing in dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This ground-breaking digital tool transforms regular metered-dose inhalers into intelligent, connected devices, improving medication adherence and management for individuals suffering from chronic respiratory illnesses, including asthma, COPD, among others. Its features include analytic sensors, and it supports patient adherence monitoring through the BreatheSmart app, which contributes to effective respiratory disease management.

View the full report here:

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

How Is the Connected Drug Delivery Devices Market Defined and What Are Its Core Parameters?

Connected drug delivery devices are smart pharmaceutical devices that utilize digital technology to monitor, manage, and control the dispensation of medications, enhancing adherence and patient outcomes. These devices can connect to the internet, allowing for data sharing between patients and healthcare providers to track medication usage, adjust dosages, and improve treatment strategies.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13962

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Connected Drug Delivery Devices Market?

The escalating significance of remote patient monitoring is anticipated to boost the expansion of the connected drug delivery device market in the future. Remote patient monitoring is an approach to healthcare provision that leverages technology to monitor patient health and medical data remotely. Connected drug delivery devices add value to RPM by ensuring precise tracking of medication usage and compliance, enabling timely interventions, and offering personalized care management. For example, a survey in August 2023 by Vivalink Inc., a US-based digital health solutions firm, revealed that there was a 305% increase in the number of clinicians adopting remote patient monitoring (RPM) for patients, from 20% in 2021 to 81% at present, with a further 84% intending to broaden their RPM usage by 2024. Consequently, the growing significance of remote patient monitoring contributes to the development of the connected drug delivery device market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp

How Has the Connected Drug Delivery Devices Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The market size for connected drug delivery devices has experienced tremendous growth lately. Projected to expand from $7.48 billion in 2024 to $9.29 billion in 2025, it signifies a compound annual growth rate (CAGR) of 24.2%. Factors contributing to the growth during the historic period include heightened awareness about connected devices, the growing significance of remote monitoring for consistent medication use, enhanced patient involvement, broad consumer acceptance, and a rapid surge in the cost of medical management.

The market size for connected drug delivery devices is anticipated to witness significant growth in the upcoming years, reaching a projected value of $21.92 billion in 2029. This corresponds to a compound annual growth rate (CAGR) of 23.9%. This burgeoning growth during the forecast period can be attributed to factors such as a high incidence rate of chronic illnesses, heightened patient awareness towards adherence to prescribed treatments, rapidly evolving healthcare IT infrastructure, increased focus on preventive health care, and the widespread use of connected devices in laboratories and hospitals for the management of electronic health records (EHR). The projected trends for the period include increased research and development activities, a surge in the innovation of technology and the enhanced connectivity of devices, rising use of machine learning and artificial intelligence, growing implementation of telehealth platforms with integration of AR/VR technologies, and an uptick in the incorporation of electronic technology in healthcare devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13962

What New Market Trends Are Reshaping theConnected Drug Delivery Devices Market and Its Opportunities?

Leading enterprises within the connected drug delivery device market are prioritizing the development of innovative technologies, for example, digital respiratory health solutions, in order to boost their market profitability. A digital respiratory health solution in the context of connected drug delivery devices is essentially a tech-powered mechanism that assists in drug delivery to the respiratory system, simultaneously tracking health and usage data to yield improved patient results. For instance, AptarGroup Inc., an American company that manufactures dispenser packaging and drug delivery devices, introduced HeroTracker Sense in February 2022. This avant-garde digital tool revolutionizes traditional metered-dose inhalers by upgrading them to smart, connected instruments to help manage medication for people suffering from chronic respiratory diseases like asthma and COPD, among others. It comes packed with features such as sensors that provide analytical insight and fosters patient compliance monitoring via BreatheSmart application, thus aiding disease management effectively.

Who Are the Leading Market Players Fueling Growth in the Connected Drug Delivery Devices Market Trend?

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

How is the Global Connected Drug Delivery Devices Market Segemented?

The connected drug delivery devices market covered in this report is segmented –

1) By Type: Standalone Components And Software, Integrated Devices

2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies

3) By Administration: Parenteral, Inhalational

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications

Subsegments:

1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software

2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp

Which Geographics are Influencing the Growth of the Connected Drug Delivery Devices Market?

North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Connected Drug Delivery Devices Market 2025, By The Business Research Company:

Oncology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Lancing Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the connected drug delivery devices market grown in recent years?

The market size of connected drug delivery devices has seen an exponential increase in the recent past. The market growth is projected to rise from $7.48 billion in 2024 to $9.29 billion in 2025, with a compound annual growth rate (CAGR) of 24.2%. The growth during the historical period is credited to heightened awareness of connected devices, growing significance of remote monitoring for medication compliance, increased patient involvement, extensive consumer adoption, and the sharply rising cost of medical management.

How is the connected drug delivery devices market size expected to evolve during the forecast period?

We anticipate the market for connected drug delivery devices to experience significant growth in upcoming years. This market is predicted to expand to $21.92 billion by 2029, reflecting a compound annual growth rate (CAGR) of 23.9%. The forecasted growth could be influenced by factors such as higher prevalence of chronic diseases, greater patient awareness and adherence to recommended treatments, rapid advancements in healthcare technology infrastructure, an increased focus on preventive care, as well as the widespread utilization of connected devices for managing electronic health records (EHR) in laboratories and hospitals. Future trends anticipated within this period involve accelerated R&D activities, a boost in technological innovation and enhanced device connectivity, increased application of machine learning and AI, growing incorporation of telehealth platforms with AR/VR technologies, and a rise in the usage of electronic technology within healthcare devices.

Get your connected drug delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Which key drivers are propelling the connected drug delivery devices market’s growth?

The anticipated expansion of the connected drug delivery device market is linked to the rising significance of remote patient monitoring. This method of healthcare delivery, which employs technology to monitor patients’ health and medical data remotely, is complemented by connected drug delivery devices. Through these devices, it’s possible to accurately monitor how patients adhere to their medication schedule, as well as trigger crucial interventions when required, and offer tailored care management. A US-based digital health solutions company, Vivalink Inc., conducted a survey in August 2023, which found a 305% surge in clinicians utilizing remote patient monitoring, rising from 20% in 2021 to 81% presently. Furthermore, a vast majority, 84%, of these users intend to broaden their use of RPM in 2024. Thus, the enhanced focus on remote patient monitoring is contributing to the advancement of the connected drug delivery device market.

What are the market segments in the connected drug delivery devices industry?

The connected drug delivery devices market covered in this report is segmented –

1) By Type: Standalone Components And Software, Integrated Devices

2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies

3) By Administration: Parenteral, Inhalational

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications

Subsegments:

1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software

2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp

Which leading companies are shaping the growth of the connected drug delivery devices market?

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

What key trends are currently impacting the connected drug delivery devices market’s development?

Leading businesses in the connected drug delivery devices market are concentrating on the creation of innovative technologies, like digital respiratory health solutions, to boost their market profitability. A digital respiratory health solution in the context of connected drug delivery devices refers to a tech-savvy device that delivers medication to the respiratory system, monitors usage, and collects health data to improve patient results. For example, in February 2022, AptarGroup Inc., an American firm specializing in dispensing packaging and drug delivery devices, launched HeroTracker Sense. This groundbreaking digital tool converts traditional metered-dose inhalers into intelligent, connected devices to improve medication compliance and management for people suffering from chronic respiratory diseases such as asthma and COPD among others. It provides sensors for enhanced analytics and insights, and supports patient adherence tracking through the BreatheSmart app, contributing to the efficient treatment of respiratory diseases.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13962

Which geographic areas are influencing the growth of the connected drug delivery devices market?

North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Oncology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Lancing Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Future CAGR of the Connected Drug Delivery Devices Market, and How Will It Impact Industry Expansion?

In recent years, there has been a significant expansion in the market size of connected drug delivery devices. The market is projected to increase from $7.48 billion in 2024 to $9.29 billion in 2025, marking a compound annual growth rate (CAGR) of 24.2%. The phenomenal growth experienced during the historical period can be ascribed to a heightened consciousness about connected devices, the growing emphasis on remote monitoring to ensure medication adherence, improved patient engagement, a broad consumer acceptance, and the swift escalation in the cost of medical management.

The market size of connected drug delivery devices is predicted to escalate tremendously in the upcoming years, reaching $21.92 billion in 2029 with a compound annual growth rate (CAGR) of 23.9%. This increase during the projected time frame can be associated with growing incidences of chronic diseases, enhanced patient knowledge about the importance of adhering to recommended treatment plans, fast-paced evolution of healthcare IT infrastructure, and the rising focus on preventive care. The period will also witness expanding use of connected devices in labs and hospitals for electronic health record (EHR) keeping. In the same time frame, trends to expect include a boost in research and development activities, a spike in technology innovations and device connectivity, an increased reliance on machine learning and artificial intelligence, a rise in the implementation of telehealth platforms with AR/VR technologies, and an expansion in the use of electronic technology in healthcare devices.

Which Drivers Are Expected to Have the Greatest Impact on the connected drug delivery devices Market’s Growth?

The burgeoning significance of remote patient surveillance is anticipated to fuel the expansion of the connected drug delivery device market. The technique of remote patient monitoring, which employs technology to observe patient health and medical information from afar, plays an instrumental role in healthcare delivery. This approach augments remote patient monitoring by allowing precise monitoring of medication consumption and adherence, prompting timely interventions, and providing tailored care management. As an illustration, in August 2023, Vivalink Inc., a digital health solutions firm based in the US, conducted a survey that presented a meteoric 305% surge in clinicians using remote patient monitoring on their patients, increasing from 20% in 2021 to 81% at present, with a staggering 84% of these users expected to enlarge their use of RPM in 2024. Therefore, the escalating significance of remote patient monitoring is steering the ascension of the connected drug delivery device market.

Get Your Free Sample of the Global Connected Drug Delivery Devices Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp

What Are the Top Market Players Propelling the Growth of the Connected Drug Delivery Devices Industry?

Major players in the connected drug delivery devices market are:

• Pfizer Inc._x000D_

• Johnson & Johnson_x000D_

• Bayer AG_x000D_

• AstraZeneca PLC_x000D_

• Abbott Laboratories_x000D_

What Are the Key Trends to Watch in the Connected Drug Delivery Devices Market Over the Coming Years?

Key players in the connected drug delivery devices market are prioritizing the development of unique technology like digital respiratory health solutions to bolster their market profitability. This type of solution for connected drug delivery devices represents a tech-enabled device that assist the delivery of medication to the respiratory system whilst monitoring usage and health statistics to enhance patient results. For example, AptarGroup Inc., a US manufacturing organisation for dispensing packaging and drug delivery devices, unveiled HeroTracker Sense in February 2022. It is a ground-breaking digital tool that converts traditional metered-dose inhalers into intelligent, connected devices, escalating medication consistency and management for sufferers of chronic respiratory diseases such as asthma, COPD, among others. Features include sensors for detailed analytics and insight, and it encourages patient adherence tracking with the BreatheSmart application, thereby aiding in the effective control of respiratory ailments.

Get Instant Access to the Global Connected Drug Delivery Devices Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Which Segments of the Connected Drug Delivery Devices Market Hold the Most Potential for Future Development?

The connected drug delivery devices market covered in this report is segmented –

1) By Type: Standalone Components And Software, Integrated Devices

2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies

3) By Administration: Parenteral, Inhalational

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications

Subsegments:

1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software

2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices

What Regions Are Dominating the Connected Drug Delivery Devices Market Growth?

North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Characteristics That Define the Connected Drug Delivery Devices Market?

Connected drug delivery devices are smart pharmaceutical devices that utilize digital technology to monitor, manage, and control the dispensation of medications, enhancing adherence and patient outcomes. These devices can connect to the internet, allowing for data sharing between patients and healthcare providers to track medication usage, adjust dosages, and improve treatment strategies.

Browse Through More Similar Reports By The Business Research Company:

Oncology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Lancing Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: